|
TSHA Taysha Gene Therapies Inc 1806310 |
| Balance Sheet |
|
Current Assets
|
161,555,000 |
|
Assets
|
180,217,000 |
|
Current Liabilities
|
29,335,000 |
|
Liabilities
|
91,420,000 |
|
Equity
|
88,797,000 |
|
Shares Out
|
204,943,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-62,917,000 |
|
Investing Cash Flow
|
-376,000 |
| Market Analysis |
Market Cap
|
412,960,770 |
|
Price
|
1.53 |
|
BVPS
|
0.43 |
|
PB
|
3.51 |
|
EPS
|
-0.90 |
|
PS
|
57.74 |
|
FCF
|
-63,293,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TSHA documents filed with the SEC.
TSHA Filings
Clear
